杨奕涛, 古雨, 陈紫嫣, 刘文斌, 曹广文. 雄激素受体在肝细胞癌发生发展中的作用[J]. 上海预防医学, 2023, 35(11): 1157-1161. DOI: 10.19428/j.cnki.sjpm.2023.22926
引用本文: 杨奕涛, 古雨, 陈紫嫣, 刘文斌, 曹广文. 雄激素受体在肝细胞癌发生发展中的作用[J]. 上海预防医学, 2023, 35(11): 1157-1161. DOI: 10.19428/j.cnki.sjpm.2023.22926
YANG Yitao, GU Yu, CHEN Ziyan, LIU Wenbin, CAO Guangwen. Role of androgen receptors in the development of hepatocellular carcinoma[J]. Shanghai Journal of Preventive Medicine, 2023, 35(11): 1157-1161. DOI: 10.19428/j.cnki.sjpm.2023.22926
Citation: YANG Yitao, GU Yu, CHEN Ziyan, LIU Wenbin, CAO Guangwen. Role of androgen receptors in the development of hepatocellular carcinoma[J]. Shanghai Journal of Preventive Medicine, 2023, 35(11): 1157-1161. DOI: 10.19428/j.cnki.sjpm.2023.22926

雄激素受体在肝细胞癌发生发展中的作用

Role of androgen receptors in the development of hepatocellular carcinoma

  • 摘要: 肝细胞癌(HCC)已成为严重威胁我国居民生命健康的重要公共卫生问题,且男性的发病率和死亡率显著高于女性。雄激素受体(AR)可促进前列腺癌等男性特异性癌症的发生,可能与HCC的男性易感性有关。阐明AR的促癌作用机制并展开特异性的靶向干预措施是促进HCC三级预防、提高患者预后的有效途径。本文梳理AR促进HCC发生发展的相关证据,总结目前发现的主要相关机制,包括促进HCC细胞干性、改变免疫微环境、调控关键信号通路、诱导HCC糖酵解以及与乙型肝炎病毒协同促进HCC,同时讨论了针对AR相关通路进行HCC靶向干预的研究方向。

     

    Abstract: Hepatocellular carcinoma (HCC) has emerged as a significant public health concern, posing a serious threat to the lives and health of residents in China. Furthermore, the incidence and mortality rates of HCC are notably higher in males than in females. Androgen receptors (AR) can contribute to the occurrence of male-specific cancers such as prostate cancer, suggesting a potential link to the increased susceptibility of males to HCC. Elucidating the cancer-promoting mechanism of AR and developing specific targeted interventions are effective ways to advance tertiary prevention of HCC and improve patient prognosis. This paper reviews the relevant evidence of AR’s role in promoting the occurrence and development of HCC, summarizes relevant mechanisms discovered to date, including promoting the stemness of HCC cells, altering the immune microenvironment, regulating key signaling pathways, inducing glycolysis in hepatocellular carcinoma, and synergizing with hepatitis B virus to promote HCC. Additionally, research directions for targeted interventions in HCC through AR-related signaling pathways are discussed.

     

/

返回文章
返回